Physician viewpoint: Drug supply chain is still ‘dysfunctional, opaque’

The latest shortage of multiple forms of pediatric medications is only a fraction of the swath of drug shortages, Megan Ranney, MD, a professor of emergency medicine at Providence, R.I.-based Brown University, wrote in an opinion published in CNN Nov. 28. 

Advertisement

Among the list of more than 120 drugs on short supply are the antibiotic amoxicillin, flu drug oseltamivir and some formulations of albuterol, which treats asthma and wheezing. Children need specific dosing, but when one point in the supply chain falls, “the system falls apart,” Dr. Ranney wrote. 

The FDA has been working to prevent drug shortages for years, but there’s little incentive to protect supply of low-profit drugs such as amoxicillin. She said that instead of prioritizing profit margins, healthcare needs to support solutions, such as Mark Cuban’s online pharmacy and nonprofit generic drug company Civica Rx. 

“Despite the best efforts to address root causes, we still have a dysfunctional, opaque medical supply chain,” Dr. Ranney wrote.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.